+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Market for Anti-obesity Drugs

  • PDF Icon

    Report

  • 67 Pages
  • November 2023
  • Region: Global
  • BCC Research
  • ID: 5910679
Description Jump to:

Report Scope

The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.

The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players’ profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes

  • An overview of the current and future global markets for anti-obesity drugs
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region
  • Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market
  • Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings
  • Profiles of the leading global players

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Research Methodology
  • Information Sources
  • Geographic Breakdown
  • Segmentation Breakdown
Chapter 2 Summary and Highlights
  • Market Outlook
  • Market Summary
Chapter 3 Market Overview
  • Definitions of Adult Obesity and Overweight
  • Overweight- and Obesity-Related Diseases
  • Rising Prevalence of Obesity
  • Impact of Obesity on Global Economy
  • Increasing Awareness Regarding Obesity
  • SWOT Analysis
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
Chapter 4 Global Market for Anti-obesity Drugs by Type
  • Prescription Drugs
  • Over-the-Counter Anti-obesity Drugs
Chapter 5 Global Market for Anti-obesity Drugs by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Chapter 6 Global Market for Anti-obesity Drugs by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 7 ESG Developments
  • Introduction to ESG
  • Importance of ESG in Anti-obesity Drugs Industry
  • ESG Pillars in the Anti-obesity Drug Industry
  • Environmental Metrics
  • Social Metrics
  • Governance Metrics
  • ESG Ratings and Metrics: Understanding the Data
  • ESG Practices in the Anti-obesity Drug Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks from the Publisher
Chapter 8 Competitive Landscape
  • Overview
  • Pipeline Analysis
  • Patents on Obesity Management, 2020-2023
Chapter 9 Company Profiles
  • Altimmune Inc.
  • Boehringer Ingelheim International Gmbh
  • Currax Pharmaceuticals Llc
  • Eli Lilly And Co.
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Rhythm Pharmaceuticals, Inc.
  • Vivus Llc
List of Tables
Summary Table: Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 1: Definitions of Adult Obesity and Overweight
Table 2: Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020-2035
Table 3: Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020-2035
Table 4: Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035
Table 5: Global Economic Impact of High BMI (BMI =25kg/m²), 2020-2035
Table 6: Global Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 7: Difference between Prescription Drugs and Over-the-Counter Anti-obesity Drugs
Table 8: Approved Prescription Drugs to Treat Overweight and Obesity
Table 9: Global Market for Anti-obesity Prescription Drugs, by Region, Through 2028
Table 10: Global Market for Over-the-Counter Anti-obesity Drugs, by Region, Through 2028
Table 11: Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 12: Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, Through 2028
Table 13: Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, Through 2028
Table 14: Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, Through 2028
Table 15: Global Market for Anti-obesity Drugs, by Region, Through 2028
Table 16: North American Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 17: North American Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 18: European Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 19: European Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 20: Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 21: Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 22: Rest of the World Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 23: Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 24: ESG Ratings and Metrics
Table 25: Environmental Performance
Table 26: Social Performance
Table 27: Governance Performance
Table 28: ESG Rankings for Major Anti-obesity Drug Companies, 2023*
Table 29: Anti-obesity Drugs in Clinical Trials, 2023
Table 30: Patents on Obesity Management, 2020-2023
Table 31: Altimmune: Pipeline Products
Table 32: Altimmune: News, 2023
Table 33: Boehringer Ingelheim: Pipeline Products
Table 34: Boehringer Ingelheim: News, 2023
Table 35: Currax Pharmaceuticals LLC: Products
Table 36: Currax Pharmaceuticals LLC: News, 2022
Table 37: Eli Lilly: Pipeline Products
Table 38: Eli Lilly: News, 2023
Table 39: ROCHE: Products
Table 40: GlaxoSmithKline: Products
Table 41: Novo Nordisk A/S: Products
Table 42: Novo Nordisk A/S: Pipeline Products
Table 43: Novo Nordisk A/S: News, 2023
Table 44: Pfizer: Pipeline Products
Table 45: Pfizer: News, 2023
Table 46: Rhythm Pharmaceuticals: Products
Table 47: Rhythm Pharmaceuticals: Pipeline Products
Table 48: Rhythm Pharmaceuticals: News, 2023
Table 49: VIVUS LLC: Products
Table 50: VIVUS LLC: News, 2023
List of Figures
Summary Figure: Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 1: Global Market for Anti-obesity Drugs: SWOT Analysis
Figure 2: Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 3: Global Market for Anti-obesity Prescription Drugs, by Region, 2021-2028
Figure 4: Global Market for Over-the-Counter Anti-obesity Drugs, by Region, 2021-2028
Figure 5: Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 6: Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, 2021-2028
Figure 7: Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, 2021-2028
Figure 8: Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, 2021-2028
Figure 9: Global Market Shares of Anti-obesity Drugs, by Region, 2023
Figure 10: North American Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 11: North American Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 12: European Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 13: European Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 14: Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 15: Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 16: Rest of the World Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 17: Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028

Executive Summary

The goal of this study is to determine the current market scenario for anti-obesity drugs, its types, and assess the distribution channels as well as to gauge the market’s growth potential during the forecast period of 2023-2028. The research explores market trends, approved anti-obesity drugs in the market, and product pipeline that is set to significantly impact the growth of the market in the coming five to ten years for anti-obesity drugs. The study provides a comprehensive analysis of the current market for antiobesity drugs and predicts the future direction of the market.

Companies Mentioned

  • Altimmune Inc.
  • Boehringer Ingelheim International Gmbh
  • Currax Pharmaceuticals Llc
  • Eli Lilly And Co.
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Rhythm Pharmaceuticals, Inc.
  • Vivus Llc

Related Topics

Related Reports

North America Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Image

North America Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • 72 Pages
  • North America
From
Asia Pacific Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Image

Asia Pacific Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • 84 Pages
  • Asia Pacific
From
Anti-Obesity Drugs: Global Strategic Business Report - Product Image

Anti-Obesity Drugs: Global Strategic Business Report

  • Report
  • 264 Pages
  • Global
From
Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029 - Product Image

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029

  • Report
  • 220 Pages
  • Global
From
Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 142 Pages
  • Global
From

About the Anti-Obesity Drugs Market

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.